Related Experiment Video
Updated: Feb 20, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
The role of acute circulatory support in ST-segment elevation myocardial infarction complicated by cardiogenic shock
Michele Esposito1, Yousef Bader1, Robert Pedicini1
1The Cardiovascular Center, Tufts Medical Center, Boston, MA, United States.
Insights
Acute mechanical circulatory support (AMCS) devices like Impella, TandemHeart, and VA-ECMO are increasingly used for ST-segment elevation myocardial infarction (STEMI) with cardiogenic shock. This review details their hemodynamic effects and clinical data for STEMI management.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- ST-segment elevation myocardial infarction (STEMI) with cardiogenic shock presents complex treatment challenges.
- Effective management requires circulatory support, ventricular unloading, and myocardial perfusion restoration.
- Percutaneously-delivered acute mechanical circulatory support (AMCS) devices have seen increased utilization.
Purpose of the Study:
- To review the hemodynamic impact of various AMCS devices.
- To summarize clinical data on AMCS use in STEMI complicated by cardiogenic shock.
- To provide an overview of Impella, TandemHeart, and VA-ECMO in this critical setting.
Main Methods:
- Literature review of percutaneously-delivered AMCS devices.
- Analysis of hemodynamic principles governing device function.
- Synthesis of clinical trial and observational data for STEMI and cardiogenic shock.
Main Results:
- AMCS devices offer distinct hemodynamic profiles for circulatory support and ventricular unloading.
- Impella, TandemHeart, and VA-ECMO represent key percutaneous AMCS options.
- Growing evidence supports the role of AMCS in improving outcomes for STEMI with cardiogenic shock.
Conclusions:
- AMCS plays a crucial role in the multifaceted treatment of STEMI complicated by cardiogenic shock.
- Understanding the specific hemodynamic effects of each device is vital for optimal patient selection.
- Further research continues to refine the application and efficacy of AMCS in this high-risk population.
Abstract:
In the setting of ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock, three primary treatment objectives include providing circulatory support, ventricular unloading, and restoring myocardial perfusion. In addition to primary percutaneous coronary intervention, each of these three objectives can be achieved with appropriate use of an acute mechanical circulatory support (AMCS) pump. Over the past decade, utilization of percutaneously-delivered AMCS devices including the Impella axial-flow catheter, TandemHeart left atrial-to-femoral artery bypass system, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has grown exponentially. In this review, we will discuss the hemodynamic impact of each AMCS device and clinical data surrounding their use in the setting of STEMI complicated by cardiogenic shock.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome V: Nursing Management
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Acute Coronary Syndrome III: Diagnostic Studies

